1. Home
  2. BGLC vs CISS Comparison

BGLC vs CISS Comparison

Compare BGLC & CISS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$3.94

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo C3is Inc.

CISS

C3is Inc.

HOLD

Current Price

$0.23

Market Cap

958.8K

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
CISS
Founded
2017
2022
Country
Malaysia
Greece
Employees
N/A
N/A
Industry
Medical Specialities
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
958.8K
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
CISS
Price
$3.94
$0.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
204.4K
1.8M
Earning Date
11-14-2025
11-18-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,465,006.00
$33,613,149.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.56
Revenue Growth
2.21
N/A
52 Week Low
$2.01
$0.20
52 Week High
$15.60
$10.69

Technical Indicators

Market Signals
Indicator
BGLC
CISS
Relative Strength Index (RSI) 33.54 18.80
Support Level $3.98 $0.21
Resistance Level $4.23 $0.24
Average True Range (ATR) 0.15 0.04
MACD 0.01 -0.01
Stochastic Oscillator 0.00 2.08

Price Performance

Historical Comparison
BGLC
CISS

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About CISS C3is Inc.

C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of its fleet is approximately 64,000 dwt.

Share on Social Networks: